Furthermore, in a xenograft model, CCL5 overexpression enhanced vascularization and tumor growth through the downregulation of miR-199a, whereas CCL5 deletion led to increased miR-199a levels, reduced VEGF expression, impaired angiogenesis, and suppressed tumor progression [159]. This evidence concerns the gene VEGFA and neoplasm.